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a b s t r a c t
Deregulation of the endocytic machinery has been implicated in human cancers. However, the
mechanism by which endocytic defects drive cancer development remains to be clariﬁed. Here, we
ﬁnd through a genetic screen in Drosophila that loss of Rab5, a protein required for early endocytic
trafﬁcking, drives non-autonomous cell proliferation in imaginal epithelium. Our genetic data indicate
that dysfunction of Rab5 leads to cell-autonomous accumulation of Eiger (a TNF homolog) and EGF
receptor (EGFR), which causes activation of downstream JNK and Ras signaling, respectively. JNK
signaling and its downstream component Cdc42 cooperate with Ras signaling to induce upregulation of
a secreted growth factor Upd (an IL-6 homolog) through inactivation of the Hippo pathway. Such non-
autonomous tissue growth triggered by Rab5 defect could contribute to epithelial homeostasis as well as
cancer development within heterogeneous tumor microenvironment.
& 2014 Published by Elsevier Inc.
Introduction
Cancer development is achieved by the acquisition of multiple
genetic alterations such as activation of oncogenes and inactiva-
tion of tumor suppressor genes (Kinzler and Vogelstein, 1996).
Accumulating evidence suggests that cancer progression is also
driven by cell–cell interactions within tumor microenvironment
(Bissell and Hines, 2011; Jacks and Weinberg, 2002). The genetic
mosaic techniques available in Drosophila allow us to analyze the
behavior of cell clones with distinct oncogenic mutations (Xu and
Rubin, 1993), making the Drosophila an ideal model organism for
studying the role of cell–cell interactions in tumor development
and progression in vivo (Brumby and Richardson, 2005; Pastor-
Pareja and Xu, 2013).
Endocytosis is an evolutionarily conserved cellular process in
which molecules on the cell surface such as various types of
ligand–receptor proteins are internalized and transported to early
endosomes, where they are either sorted into the recycling path-
way back to the cell surface or trafﬁcked to the lysosome for
degradation. Thus, the endocytic machinery can regulate cellular
signaling triggered by the cell surface proteins including oncogenic
ligand–receptor systems (Chia and Tang, 2009; Tomas et al., 2014).
Indeed, it has been shown that deregulation of the endocytic
machinery is frequently associated with human cancers (Chia and
Tang, 2009; Floyd and De Camilli, 1998; Mosesson et al., 2008).
However, the mechanism by which deregulated endocytosis drives
tumor development and progression remains elusive.
Rab5 is an evolutionarily conserved small GTPase required for
the import of endocytic materials from the cell surface and early
endocytic trafﬁcking. Studies in Drosophila have shown that Rab5
acts as a tumor-suppressor protein in imaginal epithelium. For
example, the imaginal tissue entirely mutant for rab5 gene results
in tumorous overgrowth with multi-layered epithelial structure,
an inability to terminally differentiate, and acquired invasive
characteristics; therefore, rab5 gene is termed as a “neoplastic”
tumor suppressor (Lu and Bilder, 2005). Similarly, loss-of-function
mutations in rabenosyn (rbsn), an evolutionarily conserved Rab5
effector, also exhibit “neoplastic” phenotype (Morrison et al.,
2008). Furthermore, imaginal tissues mutant for other endocytic
genes such as vps22, vps25, vps36, vps45, erupted (ept)/tsg101, and
avalanche (avl)/syntaxin-7 also result in tumorous overgrowth
(Herz et al., 2009; Morrison et al., 2008; Vaccari et al., 2009).
Interestingly, these endocytic mutant clones are eliminated from
the tissue when surrounded by wild-type cells (Ballesteros-Arias
et al., 2013), suggesting that normal epithelial tissues exert an
anti-tumor effect against oncogenic endocytic mutant cells.
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Intriguingly, some of these endocytic mutant clones stimulate
growth of surrounding wild-type tissue through autonomous
activation of Notch signaling (Giebel and Wodarz, 2006; Herz
et al., 2006; Herz et al., 2009; Moberg et al., 2005; Thompson et al.,
2005; Vaccari and Bilder, 2005), while others do not (Herz et al.,
2009; Vaccari et al., 2009). Thus, the effects and their underlying
mechanisms of deregulated endocytosis in tumorigenesis still
remain elusive.
We have recently conducted a genetic screen in Drosophila
imaginal epithelium to identify mutations that drive non-
autonomous tumor progression through cell–cell interactions.
In the screen, we found that mutations that cause mitochondrial
dysfunction cooperate with oncogenic Ras (RasV12) to induce non-
autonomous overgrowth of surrounding tissue. In this case,
mitochondrial dysfunction and Ras activation (mito-/-/RasV12)
cooperatively induce production of reactive oxygen species
(ROS), which leads to activation of JNK signaling. JNK signaling
further cooperates with Ras signaling to inactivate the Hippo
pathway, leading to upregulation of its target Unpaired (Upd, an
IL-6 homolog), thereby causes overgrowth of surrounding tissue
(Ohsawa et al., 2012). Here, we ﬁnd through the screen that loss-
of-function mutations for rab5 in RasV12-expressing cells (rab5-/-/
RasV12) induce non-autonomous overgrowth of surrounding tis-
sue. Unlike other endocytic mutations, rab5-/-/RasV12 clones did
not cause non-autonomous overgrowth through Notch signaling.
Instead, the non-autonomous overgrowth triggered by rab5-/-/
RasV12 clones is caused by the Hippo pathway-mediated Upd
induction. Interestingly, distinct from mitochondrial dysfunction,
loss of Rab5 is sufﬁcient for the Hippo pathway-mediated induc-
tion of Upd, as Rab5 defect causes activation of both JNK and Ras
signaling. Mechanistically, loss of Rab5 leads to accumulation of
Eiger (a tumor necrosis factor (TNF) homolog) and epidermal
growth factor receptor (EGFR) at the plasma membrane of mutant
cells, which results in activation of downstream JNK and Ras
signaling, respectively. Our data suggest that dysfunction of Rab5
could contribute to epithelial homeostasis and cancer develop-
ment by non-autonomous mechanisms within a heterogeneous
cell populations.
Materials and methods
Fly strains and generation of clones
Fluorescently-labeled mitotic clones (Lee and Luo, 1999; Xu and
Rubin, 1993) were produced in larval imaginal discs using the
following strains: eyFLP5, Act4yþ4Gal4, UAS-GFP; FRT82B, Tub-
Gal80 (82B tester), eyFLP5, Act4yþ4Gal4, UAS-GFP; diap1-lacZ,
FRT82B, Tub-Gal80 (82B diap1-lacZ tester), Tub-Gal80, FRT40A, UAS-
RasV12; eyFLP6, Act4yþ4Gal4, UAS-GFP (40 A Ras tester), Tub-
Gal80, FRT40A; eyFLP6, Act4yþ4Gal4, UAS-GFP (40 A tester), UAS-
p35; Tub-Gal80, FRT40A; eyFLP6, Act4yþ4Gal4, UAS-GFP (40 A
p35 tester), egr1 and UAS-Eigerregg1 (kind gifts from Masayuki
Miura), UAS-BskDN (a kind gift from Takashi Adachi-Yamada),
UAS-RafDN (a kind gift from Willis Li), UAS-Wts (a kind gift from
Tian Xu), P{wþmc¼ lacW}Rab5LL00467 (Drosophila Genetic Resource
Center, Kyoto), Stat92E06346, vps25K08904, ex-lacZ (ex697), diap1-lacZ
(thj5C8), UAS-p35, and UAS-RasV12 (Bloomington Stock Center),
UAS-upd1-RNAi (National Institute of Genetics Stock Center), and
UAS-notch-RNAi (Vienna Drosophila RNAi Center).
Histology
Larval tissues were stained with standard immunohistochem-
ical procedures using rabbit anti-Rab5 antibody (1:50) (a kind gift
from Marcos Gonzalez-Gaitan), rabbit anti-Upd polyclonal
antibody (1:500) (a kind gift from Douglas Harrison), mouse
Mmp1 monoclonal antibody (1:100 from 1:1:1 cocktail of 3A6B4,
3B8D12, and 5H7B11; DSHB), rabbit anti-Eiger abtibody R1 (1:500)
(a kind gift from Masayuki Miura), rabbit anti-Capicua polyclonal
antibody (1:300) (a kind gift from Iswar Hariharan), mouse anti-β-
galactosidase antibody (1:500; Sigma), goat anti-EGFR antibody
dl-20 (1:500; Santa Cruz Biotechnology), and were mounted with
DAPI-containing SlowFade Gold Antifade Reagent (Molecular
Probes). Images were taken with a Leica SP5 or Zeiss LSM700
META confocal microscope.
Results
Dysfunction of Rab5 causes non-autonomous overgrowth through
Upd
To study the genetic basis of tumor development through cell–
cell communications, we performed a genetic screen in Drosophila
eye imaginal disc to identify mutations that cause oncogenic
RasV12-expressing cells to induce non-autonomous growth of
surrounding tissue. Clones of cells expressing RasV12 overgrow
and develop into benign tumors in the eye disc (Karim and Rubin,
1998; Pagliarini and Xu, 2003). Using the MARCM technique (Lee
and Luo, 1999), we introduced additional homozygous mutations
by P-element insertions in GFP-labeled RasV12-expressing clones
and screened for those that triggered non-autonomous growth
(nag) (Fig. 1A), which exhibits overgrown ‘folded-eyesphenotype
in the adults (Ohsawa et al., 2012). We isolated a nag mutant (nag-
26) that bears a P-element insertion within the rab5 gene locus
(Fig. 1B–D). Immunostaining analysis revealed that nag-26 homo-
zygous clones show no detectable Rab5 protein expression in the
eye disc (Fig. 1E). In addition, the non-autonomous overgrowth
phenotype was cancelled by overexpression of wild-type Rab5
in nag-26 homozygous clones (data not shown). We further
conﬁrmed using a dominant-negative form of Rab5 (Rab5DN) or
previously reported rab5 null allele rab52 that dysfunction of Rab5
in RasV12-expressing clones indeed triggers non-autonomous tis-
sue overgrowth (Fig. S1A, data not shown). Interestingly, loss of
Rab5 seemed to be sufﬁcient to stimulate non-autonomous over-
growth, as clones of cells mutant for rab5 or expressing Rab5DN,
with simultaneous expression of the cell death inhibitor p35
(which allows rab5 deﬁcient clones to survive), also caused non-
autonomous overgrowth (Fig. 1F, Fig. S1B). We found that
Rab5DNþp35-expressing clones also induced non-autonomous
overgrowth in the wing disc (data not shown). The non-
autonomous overgrowth could be mediated by secreted growth
factors such as Upd (Giebel and Wodarz, 2006; Herz et al., 2006;
Moberg et al., 2005; Ohsawa et al., 2012; Thompson et al., 2005;
Vaccari and Bilder, 2005). Indeed, heterozygosity for Stat92E, a
component of the Drosophila JAK/STAT pathway (which is acti-
vated by Upd), in animals bearing rab5-/-/RasV12 clones notably
suppressed non-autonomous overgrowth (Fig. S1C). Furthermore,
reducing upd expression in rab5-/-/p35 clones suppressed the nag
phenotype (Fig. 1G). Consistent with these results, clones of cells
mutant for rab5 or expressing Rab5DN simultaneously expressing
p35 upregulated Upd (Fig. 1H, Fig. S2A). Importantly, upregulation
of Upd was observed in rab5-/- clones in the absence of p35
expression as well (Fig. S2B), indicating that suppression of
apoptosis by p35 is not required for the induction of Upd. These
data show a sharp contrast between Rab5 dysfunction and
mitochondrial dysfunction, as neither mitochondrial dysfunction
on its own nor the combination of mitochondrial dysfunction with
p35 expression induces Upd expression and non-autonomous
overgrowth (Ohsawa et al., 2012). Thus, loss of Rab5 seems to
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Fig. 1. Loss of Rab5 drives non-autonomous overgrowth. (A) A genetic screen for identifying mutations, in conjunction with oncogenic RasV12, that induce non-autonomous
growth of surrounding tissue. Using the MARCM system, homozygous mutations (P-element insertions) were introduced in clones of cells expressing RasV12 and GFP in
Drosophila eye imaginal disc. Non-autonomous overgrowth was assessed by eye phenotype and the size of GFP-expressing clones in the adult. (B and C) Eye of adult ﬂy
bearing GFP-labeled wild-type (B) or rab5 LL00467-/-/RasV12 clones in otherwise wild-type tissue. Light level (left) and ﬂuorescent (right) images are shown. (D) The piggyBac
line nag-26LL00467-/- has a P-element insertion in the rab5 gene locus. Exons are indicated by boxes. The coding region is marked in blue. (E) GFP-labeled rab5LL00467-/-/p35
clones were induced in eye-antennal disc and was stained with anti-Rab5 antibody. The nuclei were visualized by DAPI staining. (F) Eye of adult ﬂy bearing GFP-labeled rab5
LL00467-/-/p35 clones. Light level (F) or ﬂuorescent (F’) image is shown. (G) Eye of adult ﬂy bearing GFP-labeled rab5LL00467-/-/p35þupd-RNAi clones. Light level (left) and
ﬂuorescent (right) images are shown. (H) GFP-labeled rab5LL00467-/-/p35 clones were induced in eye-antennal disc and was stained with anti-Upd antibody. The nuclei were
visualized by DAPI staining. Genotypes are as follows: Tub-Gal80, FRT40A/FRT40A; eyFLP6, Act4yþ4Gal4, UAS-GFP/þ (B), Tub-Gal80, FRT40A, UAS-RasV12/PBac{SAstopDsRed}
LL00467, FRT40A; eyFLP6, Act4yþ4Gal4, UAS-GFP/þ (C), UAS-p35/þ or Y; Tub-Gal80, FRT40A/PBac{SAstopDsRed}LL00467, FRT40A; eyFLP6, Act4yþ4Gal4, UAS-GFP/þ (E, F,
H), and UAS-p35/þ or Y; Tub-Gal80, FRT40A, UAS-RasV12/PBac{SAstopDsRed}LL00467, FRT40A; eyFLP6, Act4yþ4Gal4, UAS-GFP/UAS-upd1-RNAi (G).
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cause non-autonomous overgrowth through Upd induction by a
distinct mechanism from mito-/-/RasV12 cells.
Loss of Rab5 induces Upd expression via inactivation of the hippo
pathway
It has been reported that clones of cells mutant for vps25 or ept,
the components of the ESCRT (endosomal sorting complex
required for transport) complexes, cause non-autonomous over-
growth in Drosophila imaginal epithelium (Giebel and Wodarz,
2006; Herz et al., 2006; Moberg et al., 2005; Thompson et al.,
2005; Vaccari and Bilder, 2005). The ESCRT complexes are required
for sorting ubiquitinated transmenbrane proteins at endosomes
into multi-vesicular bodies (MVBs), which fuse with lysosomes for
degradation of the internalized proteins. It has been shown that
loss of vps25 or ept results in elevated Notch signaling, which leads
to upregulation of its target Upd (Moberg et al., 2005; Thompson
et al., 2005; Vaccari and Bilder, 2005). Indeed, reduction in notch
expression in vps25-/- clones blocked the non-autonomous over-
growth phenotype (Fig. S3A and B). However, notch-RNAi had no
effect on the nag phenotype caused by rab5-/-/RasV12 clones
(Fig. S3C). Furthermore, we found that Rab5DNþp35 clones do
not activate Notch signaling (Fig. S3D and E). Thus, loss of an early
endosomal component Rab5 seems to cause non-autonomous
overgrowth via distinct mechanism from loss of ESCRT proteins.
Another possible mechanism by which loss of Rab5 causes Upd
induction is through inactivation of the Hippo pathway
(Karpowicz et al., 2010; Ohsawa et al., 2012; Staley and Irvine,
2010). Hippo signaling is an evolutionarily conserved kinase
cascade that phosphorylates and inactivates the transcriptional
co-activator Yokie (Yki) (Halder and Johnson, 2011; Pan, 2010;
Zhao et al., 2010). We found that clones of Rab5DNþp35 cells
upregulate Yki target genes such as expanded (ex) and diap1
(Fig. 2A and B, higher magniﬁcation images are shown in
Fig. S4). Furthermore, forced activation of the Hippo kinase cascade
by overexpressing Yki kinase Warts (Wts) in rab5-/-/p35 clones
signiﬁcantly suppressed Upd expression and non-autonomous over-
growth (Fig. 2C and D). These data suggest that loss of Rab5 causes upd
expression through inactivation of the Hippo pathway.
Loss of Rab5 induces Upd expression through Eiger-JNK signaling
We next examined the mechanism by which loss of Rab5 leads
to Yki activation. It has been reported that Yki activity is positively
regulated by JNK signaling (Ohsawa et al., 2012; Staley and Irvine,
2010; Sun and Irvine, 2011). Indeed, Rab5DNþp35 clones upregu-
lated the expression of mmp1 (Fig. 3A), a transcriptional target of
JNK signaling (Uhlirova and Bohmann, 2006). Furthermore, block-
ing JNK signaling in Rab5DNþp35 clones by a dominant-negative
form of the Drosophila JNK Bsk (BskDN) suppressed MMP1 expres-
sion (data not shown), Upd expression (Fig. 3B), as well as non-
autonomous overgrowth (Fig. 3C). These data indicate that loss of
Rab5 leads to activation of JNK signaling that contributes to Yki
activation.
We next investigated the mechanism by which loss of Rab5
causes JNK activation. In imaginal discs, JNK signaling can be
activated by a TNF superfamily ligand Eiger (Igaki et al., 2002;
Moreno et al., 2002). Signiﬁcantly, removal of eiger gene from the
entire imaginal tissue blocked non-autonomous overgrowth trig-
gered by Rab5DNþp35 clones as well as upregulation of MMP1 and
Upd in these clones (Fig. 3D and E). These data indicate that loss of
Rab5 induces Upd expression through activation of Eiger-JNK
signaling. A possible mechanism for activation of Eiger signaling
in Rab5 deﬁcient clones could be accumulation of Eiger protein in
mutant cells because of an impaired endocytosis-mediated
degradation. Indeed, Eiger protein level was upregulated in
Rab5DNþp35 clones (Fig. 3F).
Eiger-JNK signaling promotes non-autonomous growth through
Cdc42
We next sought to identify downstream component of JNK
signaling that mediates inactivation of the Hippo pathway in Rab5
deﬁcient cells. In our candidate approach, we found that Cdc42,
which has been shown to be essential for nuclear localization of
YAP (a mammalian homolog of Yki) (Reginensi et al., 2013), acts
downstream of JNK signaling to upregulate Upd. We ﬁrst observed
that blocking Cdc42 activity by a dominant-negative form of Cdc42
(Cdc42DN) signiﬁcantly suppressed Eiger/JNK-induced cell death
phenotype in the eye (Fig. 4A and B). In addition, expression of
Cdc42DN blocked nuclear translocation of Yki in Rab5DNþp35-
expressing cells (Fig. 4D, compare to Fig. 4C), suggesting the role of
Cdc42 in inactivating the Hippo pathway. Furthermore, expression
of Cdc42DN in Rab5DNþp35 clones blocked Upd induction as well
as non-autonomous overgrowth (Fig. 4E and F, higher magniﬁca-
tion images are shown in Fig. S5A and B). In contrast, expression of
Cdc42DN did not affect JNK activation in Rab5DNþp35 clones
(Fig. 4G). We also found that Cdc42 protein level was upregulated
in Rab5DNþp35 clones (Fig. S5C). These results suggest that, in
rab5 deﬁcient clones, Eiger-JNK signaling causes Upd induction
and non-autonomous growth through Cdc42.
Loss of Rab5 causes activation of Ras signaling
Our genetic data so far presented suggest that loss of Rab5
causes inactivation of the Hippo pathway through the Eiger–JNK–
Cdc42 pathway. However, JNK activation is not sufﬁcient, as clones
of cells solely activating JNK signaling in the imaginal disc do not
cause non-autonomous overgrowth (Igaki et al., 2006; Igaki et al.,
2009; Ohsawa et al., 2011), indicating that loss of Rab5 must
induce an additional downstream effect(s) essential for the inacti-
vation of the Hippo pathway. Our recent study has shown that JNK
signaling cooperates with Ras signaling to inactivate the Hippo
pathway (Ohsawa et al., 2012). Interestingly, we found that
Rab5DNþp35 clones downregulated Capicua (Cic) expression
(Fig. 5A and B), indicating that these clones possess elevated
activity of Ras signaling (Tseng et al., 2007). In addition, blocking
Ras–MAPK signaling by a dominant-negative form of Ras effector
Raf (RafDN) in Rab5DNþp35 clones blocked Upd expression
(Fig. 5C) as well as non-autonomous overgrowth (Fig. 5E). In
contrast, RafDN had no effect on the expression of JNK target
MMP1 (Fig. 5D). These data suggest that loss of Rab5 causes
activation of Eiger–JNK–Cdc42 and Ras–MAPK signaling, which
cooperate together to inactivate the Hippo pathway.
Ras signaling is activated through EGFR in Rab5 deﬁcient cells
Finally, we investigated the mechanism by which loss of Rab5
causes activation of Ras signaling. It has been shown that the
endocytic machinery negatively regulates EGFR signaling that
triggers activation of Ras signaling (Downward, 2003). Signiﬁ-
cantly, protein level of EGFR was strongly increased in
Rab5DNþp35 clones (Fig. 5F and G). Furthermore, reduced egfr
expression by egfr-RNAi in rab5-/-/p35 clones blocked Upd expres-
sion (Fig. 5H) as well as non-autonomous overgrowth (Fig. 5I). We
also found that co-activation of Cdc42 and Ras was not sufﬁcient
for Upd induction (data not shown), thus placing JNK, Cdc42, and
Ras signaling parallel in the induction of Upd. Together, these data
indicate that loss of Rab5 leads to cellular accumulation of Eiger
and EGFR, thereby triggers activation of downstream JNK, Cdc42,
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and Ras signaling, leading to the cooperation of these signaling to
cause the Hippo pathway-mediated Upd induction (Fig. 6).
Discussion
Drosophila imaginal tissue entirely mutant for rab5 results in
autonomous overgrowth and invasive behavior (Ballesteros-Arias
et al., 2013; Lu and Bilder, 2005), which makes the rab5 gene to be
a “neoplastic” tumor suppressor (Bilder, 2004). In this study, we
provide evidence that impaired Rab5 function can also promote
tumor development through cell–cell communication. Clones of
cells mutant for rab5 stimulate growth of surrounding wild-type
cells through upregulation of Upd. Given that cancers arise from a
small clone of oncogenic cells within a normal tissue, the non-
autonomous tumor progression mechanism triggered by rab5
Fig. 2. Non-autonomous overgrowth is caused through inactivation of the Hippo pathway. (A and B) GFP-labeled clones overexpressing Rab5DN and p35 were induced in
eye-antennal disc of ex-LacZ/þ (A) or diap1-LacZ/þ (B) ﬂy and was stained with anti-β-galactosidase antibody. The nuclei were visualized by DAPI staining. (C) GFP-labeled
Rab5DNþp35þWts-expressing clones were induced in eye-antennal disc and stained with anti-Upd antibody. The nuclei were visualized by DAPI staining. (D) Eye of adult
ﬂy bearing Rab5DNþp35þWts clones. Light level (left) and ﬂuorescent (right) images are shown. Genotypes are as follows: UAS-p35/þ or Y; eyFLP5, Act4yþ4Gal4, UAS-
GFP/ex-lacZ; FRT82B, Tub-Gal80/FRT82B, UAS-Rab5DN (A), eyFLP5, Act4yþ4Gal4, UAS-GFP/UAS-p35; diap1-lacZ, FRT82B, Tub-Gal80/FRT82B,UAS-Rab5 DN (B), and UAS-p35/þ or
Y; eyFLP5, Act4yþ4Gal4, UAS-GFP / UAS-Wts; FRT82B, Tub-Gal80/UAS-Rab5DN, FRT82B (C, D).
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Fig. 3. Loss of Rab5 induces Upd expression through Eiger-JNK signaling. (A) GFP-labeled Rab5DNþp35 clones were induced in the eye-antennal disc and stained with anti-
Mmp1 antibody. The nuclei were visualized by DAPI staining. (B) GFP-labeled Rab5DNþp35þBskDN clones were induced in the eye-antennal disc and stained with anti-Upd
antibody. The nuclei were visualized by DAPI staining. (C) Eye of adult ﬂy bearing Rab5DNþp35þBskDN clones. Light level (left) and ﬂuorescent (right) images are shown.
(D) Eye of adult ﬂy bearing Rab5DNþp35 clones in eiger mutant background. Light level (left) and ﬂuorescent (right) images are shown. (E) GFP-labeled Rab5DNþp35 clones
were induced in eiger mutant eye-antennal disc and stained with anti-Upd and anti-Mmp1 antibodies. The nuclei were visualized by DAPI staining. (F) GFP-labeled
Rab5DNþp35 clones were induced in the eye-antennal disc and stained with anti-Eiger antibody. The nuclei were visualized by DAPI staining. Arrowheads (yellow) indicate
representative Rab5DNþp35 clones upregulating Eiger expression. Arrow (white) indicates endogenous expression of Eiger near the morphogenetic furrow. Genotypes are as
follows: UAS-p35/þ or Y; eyFLP5, Act4yþ4Gal4, UAS-GFP/ex-lacZ; FRT82B, Tub-Gal80/FRT82B, UAS-Rab5DN (A, F), BskDN/UAS-p35; eyFLP5, Act4yþ4Gal4, UAS-GFP/þ;
FRT82B, Tub-Gal80/FRT82B, UAS-Rab5DN (B, C), and UAS-p35/eyFLP1; Act4yþ4Gal4, UAS-GFP, egr1/egr1; FRT82B, Tub-Gal80/UAS-Rab5DN, FRT82B (D, E).
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Fig. 4. Eiger-JNK signaling promotes non-autonomous growth through Cdc42. (A and B) Eiger (A) or EigerþCdc42DN (B) was expressed under the control of the eye-speciﬁc
promoter GMR. (C and D) GFP-labeled Rab5DNþp35 (C) or Rab5DNþp35þCdc42DN (D) cells were induced in the posterior compartment of the wing disc and stained with
anti-Yki antibody. Wing discs were subjected to heat-shock (37 1C) for 12 h to induce gene expression. The nuclei were visualized by DAPI staining. (E) GFP-labeled
Rab5DNþp35þCdc42DN clones were induced in the eye-antennal disc and stained with anti-Upd antibody. The nuclei were visualized by DAPI staining. (F) Eye of adult ﬂy
bearing Rab5DNþp35þCdc42DN clones. Light level (left) and ﬂuorescent (right) images are shown. (G) GFP-labeled Rab5DNþp35þCdc42DN clones were induced in the eye-
antennal disc and stained with anti-Mmp1 antibody. The nuclei were visualized by DAPI staining. Genotypes are as follows: UAS-Eigerregg1/þ; GMR-gal4/þ(A), UAS-Eigerregg1/
UAS-Cdc42DN; GMR-gal4/þ(B), UAS-p35/þ or Y; en-Gal4, UAS-GFP/þ; Tub-Gal80ts/UAS-Rab5DN, FRT82B (C), UAS-p35/þ or Y; en-Gal4, UAS-GFP/UAS-Cdc42DN; Tub-Gal80ts/UAS-
Rab5DN, FRT82B (D), and UAS-p35/þ or Y; eyFLP5, Act4yþ4Gal4, UAS-GFP/UAS-Cdc42DN; FRT82B, Tub-Gal80/UAS-Rab5DN, FRT82B (E, F, G).
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Fig. 5. Loss of Rab5 causes activation of Ras signaling. (A and B) GFP-labeled Rab5DNþp35 clones were induced in the eye-antennal disc and stained with anti-Capicua (Cic)
antibody. The nuclei were visualized by DAPI staining. (B) is high-magniﬁcation image of the boxed area in (A). (C and D) GFP-labeled Rab5DNþp35þRafDN clones were
induced in the eye-antennal disc and stained with anti-Upd (C) or anti-Mmp1 (D) antibody. The nuclei were visualized by DAPI staining. (E) Eye of adult ﬂy bearing
Rab5DNþp35þRafDN clones. Light level (left) and ﬂuorescent (right) images are shown. (F and G) GFP-labeled Rab5DNþp35 clones were induced in the eye-antennal disc and
stained with anti-EGFR antibody. The nuclei were visualized by DAPI staining. (G) is high-magniﬁcation image of the boxed area in (F). (H) GFP-labeled rab5-/-/p35þegfr-RNAi
clones were induced in the eye-antennal disc and stained with anti-Upd antibody. The nuclei were visualized by DAPI staining. (I) Eye of adult ﬂy bearing rab5-/-/p35þegfr-
RNAi clones. Light level (left) and ﬂuorescent (right) images are shown. Genotypes are as follows: UAS-p35/þ or Y; eyFLP5, Act4yþ4Gal4, UAS-GFP/þ ; FRT82B, Tub-Gal80/
FRT82B, UAS-Rab5DN (A, B, F, G), UAS-p35/þ or Y; eyFLP5, Act4yþ4Gal4, UAS-GFP/UAS-RafDN; FRT82B, Tub-Gal80/FRT82B, UAS-Rab5 DN (C, D, E), and UAS-p35/þ or Y; Tub-
Gal80, FRT40A/PBac{SAstopDsRed}LL00467, FRT40A; eyFLP6, Act4yþ4Gal4, UAS-GFP/UAS-egfr-RNAi (H, I)
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defect could be crucial for cancer development compared to its
autonomous oncogenic role. Similar non-autonomous over-
growths have been previously observed in mosaic tissues bearing
clones of cells mutant for ESCRT genes such as vps22, vps25, and
ept (Herz et al., 2006; Herz et al., 2009; Moberg et al., 2005;
Thompson et al., 2005; Vaccari and Bilder, 2005). Unlike these
ESCRT mutant clones, the non-autonomous overgrowth caused by
Rab5 defect is not mediated through Notch signaling but through
inactivation of the Hippo pathway, a frequent change observed in
many types of human cancers(Bao et al., 2011; Chan et al., 2011;
Fernandez and Kenney, 2010; Pan, 2010; Zeng and Hong, 2008;
Zhao et al., 2010). Our data also indicate that dysfunction of
endocytic machinery either at the early or late membrane trafﬁck-
ing results in upregulation of Upd through distinct mechanisms.
Thus, our ﬁndings show that deregulation of signaling at the level
of endosomal regulation causes multiple parallel signaling path-
way defects that affect each other in a non-linear manner to
promote tumorigenesis (Fig. 6).
Intriguingly, clones of cells lacking rab5 function (rab5-/-/p35 or
Rab5DNþp35 cells) exhibited enlarged nuclei (Figs. 1E and 5B),
suggesting that rab5 mutant cells undergo endoreplication. We
also noticed that inhibition of JNK signaling, Ras-Raf signaling, or
Yki activity in rab5 mutant clones not only blocked non-
autonomous overgrowth but also suppressed the polyploid induc-
tion (data not shown). Thus, it would be interesting to investigate
in the future studies the molecular link between polyploid induc-
tion and non-autonomous growth regulation
Endocytosis has long been recognized as a way to terminate
signal transduction by degrading activated receptor complexes
after internalization from the cell surface. In this study, we found
that Eiger/TNF and EGFR are accumulated at the cell surface of
rab5 mutant cells, which leads to activation of their downstream
JNK-Cdc42 and Ras–MAPK signaling. Importantly, it has been
shown in a variety of cellular and developmental systems that
endocytic machinery can also promote activation of ligand–recep-
tor signaling such as EGF-EGFR signaling in endosomes. Indeed, in
Drosophila imaginal disc, elevated endocytosis in clones of cells
mutant for apico-basal polarity gene scribble promotes transloca-
tion of Eiger from the plasma membrane to endocytic vesicles,
which results in activation of downstream JNK signaling in
endosomes (Igaki et al., 2009). These observations suggest that
deregulated endocytosis, either elevated or attenuated intracellu-
lar trafﬁcking, can trigger activation of tumor-promoting ligand–
receptor signaling such as TNF and EGF signaling.
It has been shown that clones of “undead cells” (cells exposed
to apoptotic stimuli but are rescued from cell death by a caspase
inhibitor p35) cause overgrowth of surrounding tissue by produ-
cing secreted growth factors such as Wg and Dpp, a phenomenon
called ‘apoptosis-induced proliferation’ (Mollereau et al., 2013).
The non-autonomous stimulation of neighboring cell proliferation
was found in Drosophila wing disc when massive cell death was
induced within the tissue by radiation (Haynie and Bryant, 1977).
In this case, unaffected viable cells surrounding dying cells pro-
liferate to compensate for cell loss, which is called ‘compensatory
proliferation’ (Mollereau et al., 2013). Thus, the non-autonomous
overgrowth triggered by “undead cells” is considered to be an
abnormally enhanced outcome of the compensatory proliferation.
In the physiological condition, such compensatory cell prolifera-
tion could have a role in ﬁne-tuning of normal developmental
processes and tissue homeostasis, as well as cancer development
(Bergmann and Steller, 2010; Morata et al., 2011). A similar
multicellular event with a combination of cell death and compen-
satory cell proliferation can be observed in ‘cell competition’, a
phenomenon whereby cells with higher ﬁtness actively eliminate
neighboring cells with lower ﬁtness by inducing cell death (de
Beco et al., 2012; Morata and Ripoll, 1975; Tamori and Deng, 2011;
Vincent et al., 2013). Interestingly, it has recently been shown that
clones of cells deﬁcient for rab5 are eliminated from the imaginal
disc by cell competition (Ballesteros-Arias et al., 2013). Thus,
Eiger–JNK–Cdc42 and EGFR-Ras signaling activated downstream
of Rab5 defect could have a role in compensatory cell proliferation
during cell competition. Given that the pathways examined are
evolutionarily conserved, it would be interesting to investigate
whether the non-autonomous effect of rab5 deﬁciency plays a
role in tissue homeostasis and cancer development in higher
organisms.
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